Latest News

Dartmouth Tuberculosis Vaccine Passes Important Milestone

Dartmouth Tuberculosis Vaccine Passes Important Milestone

Investigators at Dartmouth’s Geisel School of Medicine announced that two new studies of DAR-901, their investigational vaccine against tuberculosis (TB), have moved it to the forefront of new vaccines in development for global control of this deadly infectious disease.

Photo: Shutterstock

New Antibody Shows Promise for Preventing RSV in Infants

Thanks to a collaboration between the pharmaceutical company MedImmune and Geisel structural biologist Jason McLellan, PhD, a long-awaited vaccine to protect infants from RSV may soon become a reality. Their findings are featured as this month’s cover story in the journal Science Translational Medicine.